Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

231.53 +0.95 (+0.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corp

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
From Insulet Corporation
Via Business Wire
Should you consider NASDAQ:PODD for growth investing?
Exploring INSULET CORP (NASDAQ:PODD)'s growth characteristics. 
Via Chartmill
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs. 
Via MarketBeat
Topics Earnings
Exposures Financial
INSULET CORP (NASDAQ:PODD) is a candidate for growth investors. Here's why.
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD). 
Via Chartmill
Expert Ratings For Insulet
Via Benzinga
Should you consider NASDAQ:PODD for growth investing?
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD). 
Via Chartmill
Insulet Announces Changes to Board of Directors with Retirements and New Appointments
From Insulet Corporation
Via Business Wire
Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
From Insulet Corporation
Via Business Wire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
What 8 Analyst Ratings Have To Say About Insulet
Via Benzinga
Should you consider NASDAQ:PODD for growth investing?
Why INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock. 
Via Chartmill
Why the growth investor may take a look at NASDAQ:PODD.
INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
Top Stock Picks For Week Of December 25, 2023
MoneyLion Inc. is a data-driven, digital financial platform. Insulet Corporation is a leading developer, manufacturer, and marketer of the Omnipod Insulin Management System. 
Via Talk Markets
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Wall Street sees these 2023 losers as 2024 opportunities
Analysts are pointing at undervalued, oversold companies like these three S&P 500 laggards as potential investment opportunities heading into 2024. 
Via MarketBeat
Topics Stocks
Exposures US Equities
What Stocks Drove The Recent Record Rally? A Breakdown You Can't Miss
The technology sector has done well during the recent stock market rally as seen in indices such as Nasdaq 100 and S&P 500. 
Via Benzinga
Topics Stocks
Exposures US Equities
Large cap earnings trade ideas for risk-seeking investors
Positive earnings surprises (and the magnitude of surprises) are above historical norms as of late - and these three stocks could keep the party going. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Insulet Surges After Eye-Popping Earnings Growth Wallops Expectations
Insulet makes an insulin pump called Omnipod. U.S. sales are on the rise. 
Via Investor's Business Daily
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Omnipod Insulin Pump Working Well For Insulet, Lifts Annual Forecast
Insulet Corporation (NASDAQ: PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the  
Via Benzinga
Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1)
From Insulet Corporation
Via Business Wire
Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November
From Insulet Corporation
Via Business Wire
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.